{"id":"https://openalex.org/W2088415888","doi":"https://doi.org/10.1111/j.2042-7158.1982.tb00929.x","title":"Determination of Phenelzine Plasma Concentrations in Piglet and Man","display_name":"Determination of Phenelzine Plasma Concentrations in Piglet and Man","publication_year":1982,"publication_date":"1982-12-01","ids":{"openalex":"https://openalex.org/W2088415888","doi":"https://doi.org/10.1111/j.2042-7158.1982.tb00929.x","mag":"2088415888"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.1982.tb00929.x","doi":"https://doi.org/10.1111/j.2042-7158.1982.tb00929.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1982.tb00929.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111471427","display_name":"I.J. McGilveray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288894424","display_name":"Health Canada","ror":"https://ror.org/05p8nb362","country_code":"CA","type":"government","lineage":["https://openalex.org/I1288894424"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"I J McGilveray","raw_affiliation_strings":["Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2","institution_ids":["https://openalex.org/I1288894424"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001007354","display_name":"Stephen Sved","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288894424","display_name":"Health Canada","ror":"https://ror.org/05p8nb362","country_code":"CA","type":"government","lineage":["https://openalex.org/I1288894424"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S Sved","raw_affiliation_strings":["Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2","institution_ids":["https://openalex.org/I1288894424"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059314323","display_name":"David L. Wilson","orcid":"https://orcid.org/0000-0001-9763-1463","observed_orcids":["https://orcid.org/0000-0001-9763-1463"]},"institutions":[{"id":"https://openalex.org/I1288894424","display_name":"Health Canada","ror":"https://ror.org/05p8nb362","country_code":"CA","type":"government","lineage":["https://openalex.org/I1288894424"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D L Wilson","raw_affiliation_strings":["Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2","institution_ids":["https://openalex.org/I1288894424"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048225127","display_name":"Nicole Beaudoin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288894424","display_name":"Health Canada","ror":"https://ror.org/05p8nb362","country_code":"CA","type":"government","lineage":["https://openalex.org/I1288894424"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"N Beaudoin","raw_affiliation_strings":["Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bureau of Drug Research, Health Protection Branch, Health and Welfare Canada, Ottawa, Ontario, K1A 0L2","institution_ids":["https://openalex.org/I1288894424"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1288894424"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"Supplement_12","first_page":"98P","last_page":"98P"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.49459999799728394,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.49459999799728394,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.3068999946117401,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.14390000700950623,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenelzine","display_name":"phenelzine","score":1.0},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.7160000205039978},{"id":"https://openalex.org/keywords/piglets","display_name":"piglets","score":0.5759999752044678},{"id":"https://openalex.org/keywords/human","display_name":"human","score":0.515999972820282},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.7829999923706055},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7239999771118164},{"id":"https://openalex.org/keywords/comparative-pharmacokinetics","display_name":"comparative pharmacokinetics","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C100243477","wikidata":"https://www.wikidata.org/wiki/Q12002092","display_name":"Welfare","level":2,"score":0.7004057168960571},{"id":"https://openalex.org/C2781073023","wikidata":"https://www.wikidata.org/wiki/Q1747559","display_name":"Phenelzine","level":4,"score":0.6653468608856201},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5520591139793396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4972060024738312},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.3233773708343506},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3218805491924286},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.2971143126487732},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.22342205047607422},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09926337003707886},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.07989344000816345},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/j.2042-7158.1982.tb00929.x","doi":"https://doi.org/10.1111/j.2042-7158.1982.tb00929.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1982.tb00929.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2136468839"],"related_works":["https://openalex.org/W2409449393","https://openalex.org/W1967638807","https://openalex.org/W2784103272","https://openalex.org/W2325831715","https://openalex.org/W2402651126","https://openalex.org/W2399746490","https://openalex.org/W2385812329","https://openalex.org/W1998924988","https://openalex.org/W2022973122","https://openalex.org/W2045748874"],"abstract_inverted_index":{"I":[0],"J":[1],"McGilveray,":[2],"S":[3],"Sved,":[4],"D":[5],"L":[6],"Wilson,":[7],"N":[8],"Beaudoin;":[9],"Determination":[10],"of":[11,20],"Phenelzine":[12],"Plasma":[13],"Concentrations":[14],"in":[15],"Piglet":[16],"and":[17,22],"Man,":[18],"Journal":[19],"Pharmacy":[21],"Pharmacology,":[23]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}